Analyst Ratings for Roivant Sciences (ROIV) [Buys]

ROIV Rating Summary

ROIV Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ROIV
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $12.29 (+211%) * Over Last 12-Mos
Rating Score: 8.8 / 10   Percentile Rank: 87%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/29/2022 Cantor Fitzgerald
» Updated 5/24/2022
Louise Chen New Coverage Overweight
(N/A)
15.00
(N/A)
3.86
(3.95)
2.33% Details
12/15/2021 Goldman Sachs Corinne Jenkins New Coverage Buy
(N/A)
15.00
(N/A)
8.26
(3.95)
-52.18% Details
Like ROIV Ratings? Also take a look at MRNA, ABUS, DXCM

ROIV Ratings News